Click the button below to submit content to the weekly newsletter.
LAST CALL! Discovery Phase Research Mentors and Projects
Deadline: Wednesday, August 25
We are looking for active research faculty to participate in the Discovery Phase of the Medical School Curriculum by mentoring a medical student research project. Topics in clinical, translational or basic science, or in the medical humanities, including creative writing, medical history, business or law, as they pertain to medicine, are all potential areas as long as they lead to a scholarly product. Discovery is a required five-month Phase of the curriculum during which students do full time research under the direction of their chosen mentor. Students have no responsibilities during this time other than research, so projects should be substantial enough to merit 5 months of full-time effort, but also should be feasible for what is not a long period in research terms. If you have a project in mind and would like to act as a mentor, please submit your research project.
2020 DOM IT Survey Results
The DOM IT Steering Committee surveyed faculty and staff from January 5 to February 15, 2021 for utilization and satisfaction levels of DOM IT FY20 services. View Results
Apply today to participate in the University of Utah Grant Writing Coaching Group Study
Deadline: Monday, September 13
Are you finding it challenging to learn the intricacies of writing NIH-style research proposals? Do you struggle with making a compelling case to reviewers for the importance of your research project? Are you having trouble getting consistent feedback from experts as you write research proposals? During the study, participants develop drafts of core sections of their own grant proposal, then meet as a small group every other week (8 two-hour virtual meetings) to receive critical feedback on their work-in-progress from a skilled grant writing coach and peers in their group. Groups are led by an experienced grant writing coach (senior NIH-funded investigator) who has been specially trained in the coaching group model. Learn more NIH Loan Repayment Programs (LRP) Application Cycle Opens on September 1
Deadline: Thursday, November 18
Awardees can receive up to $100,000 of qualified educational debt repayment with a two-year contract. Be sure to visit www.lrp.nih.gov to take advantage of all of the available resources, and to learn more about eligibility requirements, application dates, and all of the benefits of the NIH LRPs!
Georgia Department of Public Health Daily Status Report
View information on COVID-19 in the State of Georgia including confirmed cases, ICU admissions, hospitalizations, and deaths. Charts present the number of newly confirmed COVID-19 cases over time and are meant to aid understanding of whether the outbreak is growing, leveling off, or declining to help guide COVID-19 response. COVID-19 Vaccine Dashboard
Interactive dashboard with information about vaccines administered, vaccination by county, and race and ethnicity data.
Need help navigating the DOM Research Administration Service (RAS) Unit?
The team has issued a one-page document to assist you in working your way through the grant submission process.
If interested in submitting a proposal, please reach out to the DOM RAS Pre-Award Inbox at least 45 days in advance with the following information; due date, sponsor, and project duration. Please provide the RFA/PA or link from the sponsor.
Funding & Award Opportunities
Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional)
Deadlines: Friday, October 15, February 16, 2022, June 16, 2022, October 16, 2022
The purpose of this Funding Opportunity Announcement (FOA) is to provide support for new investigators from diverse backgrounds, including from groups nationally underrepresented in biomedical, clinical, behavioral and social sciences research, to conduct small research projects. Learn more Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)
Deadlines: New – Wednesday, October 27; Resubmissions – Friday, November 12
The purpose of this FOA is to help rigorous and promising postdoctoral researchers complete needed, mentored training and transition in a timely manner to independent, tenure-track or equivalent faculty positions. Learn more Deciphering Immune-CNS Interactions in HIV Utilizing In-Vitro and In-Vivo Model Systems (R21 Clinical Trial Not Allowed)
Deadlines: Friday, November 5 (LOI); Tuesday, December 7 (Full application)
The purpose of this Funding Opportunity Announcement (FOA) is to support studies to comprehend the mechanisms contributing to the CNS co-morbidities in people living with HIV (PLHIV) on Anti-Retroviral therapy (ART) by deciphering the Immune-Central Nervous System (CNS) interactions utilizing novel in-vitro and in-vivo model systems. Learn more Innovative Multi-Level Approaches and Strategies to Prevent, Test and Treat HIV in Primary Care Settings in Health Disparity Populations in Geographic Hot
Spots in the United States (R01 Clinical Trial Required)
Deadlines: Tuesday, December 14 (LOI); Friday, January 14, 2022 (Full application)
The purpose of this FOA is to support research projects that examine innovative approaches and strategies to prevent, test and treat HIV among health disparity populations or subgroups within primary care settings located in geographic areas with a high rate of new infections in the United States. Learn more Bold New Bioengineering Research for Heart, Lung, Blood and Sleep Disorders and Diseases (Reissue)
Deadline: Friday, January 7
The purpose of this FOA is to support early phases of innovative bioengineering projects which are expected to transition their research into future follow-on funding, technologies, or commercial products. Learn more Emerging Investigator Award (EIA) (R35 Clinical Trial Optional)
Deadline 30 days prior (LOI); Tuesday, February 15, 2022
The purpose of this FOA is to promote scientific productivity and innovation by providing long-term support and increased flexibility to experienced Program Directors/Principal Investigators (PD/PIs) who are currently PD/PIs on at least two NHLBI R01-equivalent awards and whose outstanding record of research demonstrate their ability to make major contributions to heart, lung, blood and sleep (HLBS) research. Learn more Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24
– Clinical Trial Not Allowed)
Deadlines: Monday, January 17 (LOI), Thursday, February 17 (Full application)
The purpose of this Funding Opportunity Announcement (FOA) is to support a coordinating center (CC), which will coordinate research efforts across the NIDA funded longitudinal cohorts that address emerging and high priority research on HIV/AIDS in the context of substance use and substance use disorders (SUD). Learn more
COVID-19 Funding Opportunities
Visit the DOM intranet for archived COVID funding opportunities in a searchable database compiled from FOAs in the weekly What's Up in DOM Research newsletter.
Emory credentials required to view.
Social, Behavioral, and Economic Impact of COVID-19 in Underserved and Vulnerable Populations
Deadline: September 8, 2024
The purpose of this FOA is to highlight interest in research to strengthen the understanding and response to the Coronavirus Disease 2019 (COVID-19) pandemic and help us prepare more effectively for future public health emergencies. Learn more
Soroosh Kiani (Cardiology) received funding from Abbott Cardiovascular Systems, Inc. for a project entitled, “Assess the safety and performance of Perclose ProGlide suture-mediated closure system and the Perclose ProStyle suture-mediated closure and repair system in managing multiple venous access sites.” Srilatha Edupuganti (Infectious Diseases) received funding from Fred Hutchinson Cancer Research Center/NIAID for a project entitled, “CoVID-19 Prevention Network (CoVPN) site preparedness funding.” William Nicholson (Cardiology) received
funding from Boston Scientific Corporation for a project entitled, “A prospective randomized multicenter trial to assess the safety and effectiveness of the agent paclitaxel coated PTCA balloon catheter for the treatment of subjects with in-stent restenosis.” Louise Hecker (Pulmonary) received funding from University of Arizona/Army Medical Research and Material Command (AMRMC) for a project entitled, “Preclinical development of small-molecule inhibitors targeting Nox4
for pulmonary fibrosis.”
Have you or a colleague recently received an award or grant funding?
Recent Notable Publications
Arpita Basu (Renal Medicine)
Wen J, Basu A, Bentall A, Henderson N, Dukek B, Gandhi M, Schinstock C. Is the level of HLA eplet mismatch a risk factor for graft loss among kidney transplant recipients who have already formed de novo donor specific antibody? Hum Immunol. 2021 Apr;82(4):240-246. Read more Modele Ogunniyi
(Cardiology)
Butt JH, Docherty KF, Petrie MC, Schou M, Kosiborod MN, O'Meara E, Katova T, Ljungman CEA, Diez M, Ogunniyi MO, et al. Efficacy and safety of Dapagliflozin in men and women with heart failure with reduced ejection fraction: A prespecified analysis of the Dapagliflozin and prevention of adverse outcomes in heart failure trial. JAMA Cardiol. 2021 Jun 1;6(6):678-689. Read more Tracey Henry (General Medicine)
Alcegueire K, Henry TL. It is time to address the needs of socioeconomically disadvantaged medical students. Acad Med. 2021 Jan 1;96(1):15. Read more Neal Bhatia, Soroosh Kiani, Faisal Merchant, David De Lurgio, Anshul Patel, Angel Leon, Michael Lloyd, Stacy Westerman, Anand Shah, Mikhael El-Chami (Cardiology)
Bhatia NK, Kiani S, Merchant FM, Delurgio DB, Patel AM, Leon AR, Lloyd MS, Westerman SB, Shah AD, El-Chami MF. Life cycle management of Micra transcatheter pacing system: Data from a high-volume center. J Cardiovasc Electrophysiol. 2021 Feb;32(2):484-490. Read more Guillermo Umpierrez, Francisco Pasquel, Rodolfo Galindo, Priyathama Vellanki, Maya
Fayfman, Georgia Davis, Alexandra Migdal (Endocrinology)
Pasquel FJ, Urrutia MA, Cardona S, Coronado KWZ, Albury B, Perez-Guzman MC, Galindo RJ, Chaudhuri A, Iacobellis G, Palacios J, Farias JM, Gomez P, Anzola I, Vellanki P, Fayfman M, Davis GM, Migdal AL, Peng L, Umpierrez GE. Liraglutide hospital discharge trial: A randomized controlled trial comparing the safety and efficacy of liraglutide versus insulin glargine for the management of patients with type 2 diabetes after hospital discharge. Diabetes Obes Metab. 2021 Jun;23(6):1351-1360. Read more
Have you or a colleague recently published an article?
Team Science Skill Series: “Crash Course” on Team Science
Friday, August 27 ǀ noon – 2 p.m. ǀ Zoom
Establishing and maintaining a productive research team is a difficult challenge across all stages of an academic career. The science of good teamwork applies across an academic career: from incorporating graduate students and post-docs to your first research team to crossing boundaries in the creation and maintenance of an interdisciplinary expert team. In conjunction with Georgia CTSA, we are offering a “crash course” workshop that aims to develop the skills necessary to build and maintain your research team by leveraging existing teams research. This 120-minute workshop will cover the basics of team science and will be followed up by deeper dives into specific topics in future 60-minute workshops. Graduate students, post-doctoral fellows, and all levels of academic faculty are all welcome to attend this workshop. Register Discovery Research Fair
Monday, August 30 ǀ 4:30 – 5 p.m. ǀ SOM Lobby
Discovery is a required five-month Phase of the curriculum during which students do full time research under the direction of their chosen Mentor. Students must be officially paired with a Mentor by December 2021 for the upcoming year. The fair allows students to learn about potential mentors. Learn more 2021 DOM Honors and Awards Celebration
Tuesday, September 14 ǀ 5:30 – 7:30 p.m. ǀ Zoom
Please join the Department of Medicine for a virtual celebration of faculty and staff honors and awards. This annual event will honor our faculty and staff award nominees, clinical distinctions, and senior promotions.
Space is limited. Please RSVP by Monday, August 30th. Register Export controls in research and academic settings
Wednesday, September 22 ǀ 4 – 5 p.m.
Do you know what happens if you violate export controls? The ordinary meaning of the term export, where a physical item is transferred to a foreign location is well understood. Export regulations, however, apply equally to intangible property such as information and technology. This webinar will explain how to stay out of trouble with the new export regulations. The Learning Objectives for this workshop include:
1. Provide an overview of export control regulations
2. Highlight types of activities impacted by the regulations
3. Provide a summary of research and academic activities that are not subject to export control regulations
Register
Do you have an upcoming event or educational opportunity?
Laurence Busse
Assistant Professor – Pulmonary, Allergy, Critical Care, and Sleep Medicine What is your professional background?
I completed my medical education at George Washington University, where I stayed on for my internal medicine residency, and fellowship training in critical care medicine. Thereafter, I worked as an intensivist at Inova Fairfax Medical Center in northern Virginia before joining Emory University in 2016. I originally worked as an intensivist in 2E and 2W ICU at Emory Saint Joseph’s Hospital, where I was also the medical director of critical care. In 2018, I shifted my clinical work to a new critical care section at Emory Johns Creek, where I currently serve as medical director for critical care. Prior to my medical career, I received my Master of Business Administration from Emory University and worked in the financial sector. In what division do you work, and who is your mentor?
I am an assistant professor in the Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine. I am fortunate to have many mentors who have helped to guide me including Jon Sevransky and Greg Martin, both of my division, as well as Craig Coopersmith and Tim Buchman from the Department of Surgery. Briefly describe your research. Why is it important?
My research focuses on catecholamine-resistant septic shock, and the utilization of the renin-angiotensin-aldosterone system (RAAS) angiotensin II to support blood pressure. Currently, I am exploring the role of angiotensin II in non-septic shock states, like post-cardiovascular surgery vasoplegia or cardiogenic shock. I am also trying to answer the question of whether one vasopressor class works better than another in various clinical scenarios. As part of this effort, I am evaluating serum renin as a theragnostic to indicate RAAS failure in shock. What do you like most about Emory?
I feel totally supported balancing my clinical and administrative work with my research. Additionally, there’s a real commitment at every level, from my division director Dr. David Guidot to administration at my hospital (EJCH), to support my efforts to shape my career as I see fit. Because of this, I have been able to achieve a real sense of balance professionally and personally. What is your favorite movie or TV show?
I am a science fiction junkie and enjoy movies or shows with a post-apocalyptic theme (i.e., "Interstellar," "The Matrix," and "Inception"). What do you like to do in your spare time?
I am an avid Chicago Cubs fan and try to watch all of their games. I’m also teaching my 11-year-old son how to golf (and he can already out-drive me). What is a fun fact about you?
I love the mountains, but don’t like cold weather. I don’t care for the beach but love hot summer days. So north Georgia and Tennessee are my perfect places, which is ironic because I was raised in northern Illinois (basically the opposite).
"What's Up" is brought to you by Emory University's Department of Medicine Office of Research.
|